Condition

RAD51 Gene Mutation

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

3 shown

Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsNCT04030559 · 2020-02-25

TERMINATED

Olaparib In Metastatic Breast CancerNCT03344965 · 2018-04-01

ACTIVE_NOT_RECRUITING

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung CancerNCT03377556 · 2017-03-03

COMPLETED

Common interventions

Laboratory Biomarker AnalysisOTHER1NiraparibDRUG1Niraparib Tosylate MonohydrateDRUG1OlaparibDRUG1Pharmacological StudyOTHER1Radical ProstatectomyPROCEDURE1TalazoparibDRUG1

Leading sponsors

Beth Israel Deaconess Medical Center1SWOG Cancer Research Network1University of California, Davis1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

TERMINATED1

Phase mix

PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.